Jill Henrich - Nov 18, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, Chief Regulatory Officer
Signature
/s/ John Chao, Attorney-in-Fact for Jill Henrich
Stock symbol
ATRA
Transactions as of
Nov 18, 2024
Transactions value $
-$11,198
Form type
4
Date filed
11/20/2024, 06:05 PM
Previous filing
Aug 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$11.2K -1K -4.91% $11.20 19.4K Nov 18, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 18, 2024 and November 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.